Noho Inc (DRNK) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
8340 E. RAINTREE DR., UNIT D SCOTTDALE, AZ 85260 |
| State of Incorp. | WY |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2014 MRQ | 12/31/2013 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 19 | |||
| Cash and cash equivalent | 19 | |||
| Receivables | 487 | |||
| Inventory, net of allowances, customer advances and progress billings | 73 | |||
| Inventory | 73 | |||
| Prepaid expense | 116 | |||
| Other undisclosed current assets | (437) | |||
| Total current assets: | 259 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 9 | |||
| Intangible assets, net (including goodwill), including: | 132 | |||
| Other undisclosed intangible assets, net (including goodwill) | 132 | |||
| Total noncurrent assets: | 142 | |||
| TOTAL ASSETS: | 401 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,036 | |||
| Employee-related liabilities | 727 | |||
| Accounts payable | 305 | |||
| Accrued liabilities | 3 | |||
| Debt | 125 | |||
| Due to related parties | 206 | |||
| Other undisclosed current liabilities | 456 | |||
| Total current liabilities: | 1,822 | |||
| Noncurrent Liabilities | ||||
| Total liabilities: | 1,822 | |||
| Equity | ||||
| Equity, attributable to parent, including: | (1,421) | |||
| Common stock | 17 | |||
| Additional paid in capital | 3,633 | |||
| Other undisclosed equity, attributable to parent | (5,071) | |||
| Other undisclosed equity | 0 | |||
| Total equity: | (1,421) | |||
| TOTAL LIABILITIES AND EQUITY: | 401 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2014 TTM | 12/31/2013 | ||
|---|---|---|---|
| Revenues | 546 | ||
| Cost of revenue (Cost of Product and Service Sold) | (531) | ||
| Gross profit: | 15 | ||
| Operating expenses | (2,574) | ||
| Other operating income, net (Other Expenses) | 190 | ||
| Operating loss: | (2,370) | ||
| Interest and debt expense | (31) | ||
| Loss from continuing operations: | (2,401) | ||
| Loss before gain (loss) on sale of properties: | (2,401) | ||
| Net loss: | (2,401) | ||
| Other undisclosed net loss attributable to parent | (348) | ||
| Net loss available to common stockholders, diluted: | (2,749) | ||
Comprehensive Income ($ in thousands)
| 9/30/2014 TTM | 12/31/2013 | ||
|---|---|---|---|
| Net loss: | (2,401) | ||
| Comprehensive loss, net of tax, attributable to parent: | (2,401) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.